Enzon Pharmaceuticals (ENZN)
Enzon Pharmaceuticals Valuation Percentage: 2.46%
View ENZN Valuation Percentage with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
ENZN Valuation Percentage Rankings
| Overall | 49th percentile | 1718 of 3410 |
| Sector | 47th percentile | 164 of 312 in Healthcare |
| Industry | 49th percentile | 34 of 67 in Biotechnology |
ENZN Valuation Percentage Range, Past 5 Years
| Minimum | -127.6% | Dec 2009 |
| Maximum | 14.10% | Jun 2010 |
| Average | -46.28% |
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
Learn More
You may also be interested in these ENZN related companies
ENZN News
$ENZN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FPH
about 53 days ago by MarketBrief
about 53 days ago by MarketBrief
Icahn Capital's George Hebard Named as Director on Enzon Pharma (ENZN) Board
Feb 28, 5:17PM Street Insider
Feb 28, 5:17PM Street Insider
@TER_Intraday nice Fry Pan bottom in $ENZN since early Dec. Thanks for that.
about 123 days ago by 1nvestor
about 123 days ago by 1nvestor
EBR: Watchlist/worksheet/3Trading Ideas: $POT $IACI $ENZN http://stks.co/27m6
about 123 days ago by TER_Intraday
about 123 days ago by TER_Intraday
$ENZN http://stks.co/1VXa Biotech name. Flagging right under the 50MA. Watch the $7.15 level.
about 168 days ago by VexTrades
about 168 days ago by VexTrades
Enzon Presents Data From Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer
Dec 08, 6:15PM Marketwire
Dec 08, 6:15PM Marketwire
$ENZN http://stks.co/1Q88 Long setup for a short term trade. Tight price action in small wedge after recent strong buy volume
about 174 days ago by ToddinFL
about 174 days ago by ToddinFL
$ENZN http://stks.co/1ONJ Heavy short interest may have been taken out last week. Seth Klarman & Carl Icahn own 30% of shares.
about 175 days ago by drdebt
about 175 days ago by drdebt
Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting
Nov 12, 1:00PM Marketwire
Nov 12, 1:00PM Marketwire
Enzon COO Ralph Del Campo steps down, CFO Ana I. Stancic promoted to COO
Oct 17, 4:25PM FlyOnTheWall
Oct 17, 4:25PM FlyOnTheWall
Enzon Pharma (ENZN) Promotes CFO Stancic to COO; Forms Special Committee
Oct 17, 4:14PM Street Insider
Oct 17, 4:14PM Street Insider
Enzon Announces Promotion of CFO Ana I. Stancic to COO; Continues to Serve as CFO
Oct 17, 4:14PM Benzinga
Oct 17, 4:14PM Benzinga
Iridian Asset Management Raises Stake in Enzon Pharmaceuticals, Inc. (ENZN) to 11.6%
Oct 06, 1:47PM Street Insider
Oct 06, 1:47PM Street Insider
Enzon $ENZN to Cut Workforce by 48% to Support R&D Activities, Sees Q3 Charge ~$3M
about 249 days ago by Street_Insider
about 249 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ENZN | 6.32 | +0.16 | +2.60% | 305.19M |
| DWSN | 24.95 | +0.07 | +0.28% | 197.60M |
| DWRI | None | None | None | |
| DWM | 39.25 | -0.11 | -0.27% | |
| DWCH | 12.06 | -0.17 | -1.39% | 75.25M |
| DWA | 17.85 | +0.13 | +0.73% | 1.500B |
| DW | 26.41 | -0.21 | -0.79% | 587.36M |
| DVY | 54.98 | -0.09 | -0.16% | |
| DVOX | 1.51 | +0.00 | +0.00% | 15.89M |
| DVN | 60.02 | -0.41 | -0.68% | 24.25B |
